Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.
The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Towards an endophenotype in multiple sclerosis.
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography.
The importance of IL-33 in allergic inflammation.
Tissue structure and inflammatory processes shape viscoelastic properties of the mouse brain.
Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Psychological well-being in people with multiple sclerosis in an Iranian population.
The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Uhthoff's phenomenon as the first manifestation of multiple sclerosis in an adult male.
Disease-modifying agents in multiple sclerosis.
Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia.
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments.

Pages